This article explores the potential of targeting epigenetic enzymes — proteins that regulate gene activity without changing the DNA sequence — as a therapeutic approach for autism spectrum disorder. Epigenetic mechanisms are increasingly recognized as playing a role in autism-related conditions, including White-Sutton syndrome, which is caused by variants in the POGZ gene. The full text is available via subscription.